Dynamic ctDNA tracking stratifies relapse risk for triple negative breast cancer patients receiving neoadjuvant chemotherapy

Related articles

1. Higher Blood-to-Tissue Tumor Mutational Burden Ratio Is Associated With Poorer Overall Survival in Advanced Non-Small Cell Lung Cancer

   This article has 7 authors:

   1. Leeseul Kim
   2. Jongyeop Kim
   3. Jongwoo Kim
   4. Seungah Yoo
   5. Minkyu Shin
   6. Lucas Santana Dos Santos
   7. Young Kwang Chae

2. Tumor-adjacent B cell infiltration stratifies recurrence risk in localized prostate cancer

   This article has 34 authors:

   1. Binbin Wang
   2. Sumit Mukherjee
   3. Anna Baj
   4. Shana Y. Trostel
   5. Rosina T. Lis
   6. Nichelle C. Whitlock
   7. Anson T. Ku
   8. Kayla E. Heyward
   9. Sumeyra Kartal
   10. Kun Wang
   11. Olga S. Voznesensky
   12. Carla Calagua
   13. Javed Siddiqui
   14. Rabia S. Martin
   15. Lori A. Kollath
   16. Julian Custer
   17. Patrick D. Michael
   18. L. Priya Kunju
   19. Ross Lake
   20. Curtis C. Harris
   21. Kenneth D. Aldape
   22. Lawrence D. True
   23. Curtis Tatsuoka
   24. Elana J. Fertig
   25. Arul Chinnaiyan
   26. Sandeep Gurram
   27. Peter A. Pinto
   28. Adam B. Weiner
   29. Colm Morrissey
   30. Simpa S. Salami
   31. David J. Einstein
   32. Steven P. Balk
   33. Adam G. Sowalsky
   34. Eytan Ruppin

3. Evaluation of Urinary Circulating Tumor DNA to Detect Minimal Residual Disease in Patients with High-Risk Non-Muscle Invasive Bladder Cancer

   This article has 24 authors:

   1. Roger Li
   2. Joshua Linscott
   3. Prithvi Murthy
   4. Kyle Rose
   5. Young Pak
   6. Frank Zhang
   7. Yong Huang
   8. G. Daniel Grass
   9. Jonathan Chatzkel
   10. Noah M. Hahn
   11. David J. McConkey
   12. Joshua J. Meeks
   13. Siamak Daneshmand
   14. Thomas W. Flaig
   15. Seth P. Lerner
   16. Logan Zemp
   17. Michael A. Poch
   18. Philippe E. Spiess
   19. Wade J. Sexton
   20. Scott M. Gilbert
   21. Hongzhi Xu
   22. Pan Du
   23. Shidong Jia
   24. Xuefeng Wang